Literature DB >> 8659522

Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats.

D C Rubinsztein1, J Leggo, R Coles, E Almqvist, V Biancalana, J J Cassiman, K Chotai, M Connarty, D Crauford, A Curtis, D Curtis, M J Davidson, A M Differ, C Dode, A Dodge, M Frontali, N G Ranen, O C Stine, M Sherr, M H Abbott, M L Franz, C A Graham, P S Harper, J C Hedreen, M R Hayden.   

Abstract

Abnormal CAG expansions in the IT-15 gene are associated with Huntington disease (HD). In the diagnostic setting it is necessary to define the limits of the CAG size ranges on normal and HD-associated chromosomes. Most large analyses that defined the limits of the normal and pathological size ranges employed PCR assays, which included the CAG repeats and a CCG repeat tract that was thought to be invariant. Many of these experiments found an overlap between the normal and disease size ranges. Subsequent findings that the CCG repeats vary by 8 trinucleotide lengths suggested that the limits of the normal and disease size ranges should be reevaluated with assays that exclude the CCG polymorphism. Since patients with between 30 and 40 repeats are rare, a consortium was assembled to collect such individuals. All 178 samples were reanalyzed in Cambridge by using assays specific for the CAG repeats. We have optimized methods for reliable sizing of CAG repeats and show cases that demonstrate the dangers of using PCR assays that include both the CAG and CCG polymorphisms. Seven HD patients had 36 repeats, which confirms that this allele is associated with disease. Individuals without apparent symptoms or signs of HD were found at 36 repeats (aged 74, 78, 79, and 87 years), 37 repeats (aged 69 years), 38 repeats (aged 69 and 90 years), and 39 repeats (aged 67, 90, and 95 years). The detailed case histories of an exceptional case from this series will be presented: a 95-year-old man with 39 repeats who did not have classical features of HD. The apparently healthy survival into old age of some individuals with 36-39 repeats suggests that the HD mutation may not always be fully penetrant.

Entities:  

Mesh:

Year:  1996        PMID: 8659522      PMCID: PMC1915122     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  24 in total

Review 1.  When more is less: pathogenesis of glutamine repeat neurodegenerative diseases.

Authors:  C A Ross
Journal:  Neuron       Date:  1995-09       Impact factor: 17.173

2.  Limited expansion of the (CAG)n repeat of the Huntington gene: a premutation (?).

Authors:  E Legius; H Cuppens; H Dierick; K Van Zandt; R Dom; J P Fryns; G Evers-Kiebooms; M Decruyenaere; K Demyttenaere; P Marynen
Journal:  Eur J Hum Genet       Date:  1994       Impact factor: 4.246

3.  CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1.

Authors:  Y Kawaguchi; T Okamoto; M Taniwaki; M Aizawa; M Inoue; S Katayama; H Kawakami; S Nakamura; M Nishimura; I Akiguchi
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

4.  SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat.

Authors:  E N Burright; H B Clark; A Servadio; T Matilla; R M Feddersen; W S Yunis; L A Duvick; H Y Zoghbi; H T Orr
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

5.  Hereditary late-onset chorea without significant dementia: genetic evidence for substantial phenotypic variation in Huntington's disease.

Authors:  J W Britton; R J Uitti; J E Ahlskog; R G Robinson; B Kremer; M R Hayden
Journal:  Neurology       Date:  1995-03       Impact factor: 9.910

6.  Early loss of neostriatal striosome neurons in Huntington's disease.

Authors:  J C Hedreen; S E Folstein
Journal:  J Neuropathol Exp Neurol       Date:  1995-01       Impact factor: 3.685

7.  Study of the Huntington's disease (HD) gene CAG repeats in schizophrenic patients shows overlap of the normal and HD affected ranges but absence of correlation with schizophrenia.

Authors:  D C Rubinsztein; J Leggo; S Goodburn; T J Crow; R Lofthouse; L E DeLisi; D E Barton; M A Ferguson-Smith
Journal:  J Med Genet       Date:  1994-09       Impact factor: 6.318

8.  Sex-dependent mechanisms for expansions and contractions of the CAG repeat on affected Huntington disease chromosomes.

Authors:  B Kremer; E Almqvist; J Theilmann; N Spence; H Telenius; Y P Goldberg; M R Hayden
Journal:  Am J Hum Genet       Date:  1995-08       Impact factor: 11.025

9.  Huntington's disease: two families with differing clinical features show linkage to the G8 probe.

Authors:  S E Folstein; J A Phillips; D A Meyers; G A Chase; M H Abbott; M L Franz; P G Waber; H H Kazazian; P M Conneally; W Hobbs
Journal:  Science       Date:  1985-08-23       Impact factor: 47.728

10.  Mutational bias provides a model for the evolution of Huntington's disease and predicts a general increase in disease prevalence.

Authors:  D C Rubinsztein; W Amos; J Leggo; S Goodburn; R S Ramesar; J Old; R Bontrop; R McMahon; D E Barton; M A Ferguson-Smith
Journal:  Nat Genet       Date:  1994-08       Impact factor: 38.330

View more
  127 in total

1.  Aggregation of truncated GST-HD exon 1 fusion proteins containing normal range and expanded glutamine repeats.

Authors:  B Hollenbach; E Scherzinger; K Schweiger; R Lurz; H Lehrach; E E Wanker
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

Review 2.  Transgenic models of Huntington's disease.

Authors:  K Sathasivam; C Hobbs; L Mangiarini; A Mahal; M Turmaine; P Doherty; S W Davies; G P Bates
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

3.  Huntington's disease: a clinical, genetic and molecular model for polyglutamine repeat disorders.

Authors:  P S Harper
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

4.  Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.

Authors:  P H Reddy; V Charles; M Williams; G Miller; W O Whetsell; D A Tagle
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

5.  Distinguishing genetic from nongenetic medical tests: some implications for antidiscrimination legislation.

Authors:  Joseph S Alper; Jon Beckwith
Journal:  Sci Eng Ethics       Date:  1998-04       Impact factor: 3.525

6.  An upstream open reading frame impedes translation of the huntingtin gene.

Authors:  Joseph Lee; Eun Hee Park; Graeme Couture; Isabelle Harvey; Philippe Garneau; Jerry Pelletier
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

7.  Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation.

Authors:  S Waelter; A Boeddrich; R Lurz; E Scherzinger; G Lueder; H Lehrach; E E Wanker
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

8.  Predictive testing for Huntington's disease: ten years' experience in two Italian centres.

Authors:  P Mandich; G Jacopini; E Di Maria; G Sabbadini; G Abbruzzese; F Chimirri; E Bellone; A Novelletto; F Ajmar; M Frontali
Journal:  Ital J Neurol Sci       Date:  1998-04

Review 9.  Huntingtin in health and disease.

Authors:  Anne B Young
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

Review 10.  Huntington's disease: a decade beyond gene discovery.

Authors:  Penelope Hogarth
Journal:  Curr Neurol Neurosci Rep       Date:  2003-07       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.